Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.

doi:10.1016/J.JURO.2007.01.112

Paper

Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.

Published Jun 1, 2007 · Eric Smith, M. Schwartz, H. Kawamoto

The Journal of urology

Q1 SJR score

66

Citations

2

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Imidazoquinolines show potent direct activity against bladder cancer cells by decreasing cell viability and inducing apoptosis and cytokine production, suggesting therapeutic potential as a synthetic intravesical agent against bladder cancer.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.

References

Citations